Fibrin and fibrinogen degradation products in plasma of patients with colorectal adenocarcinoma

Diseases of the Colon and Rectum

Volumn 39, Issue 10, 1996, Pages 1102-1106

  Okholm, Mette ^a   Iversen, Lene H ^b   Thorlacius Ussing, Ole ^b   Ejlersen, Ejler ^b   Boesby, Steen ^a  

^a GLOSTRUP UNIVERSITY HOSPITAL   (Denmark)

^b AALBORG UNIVERSITY HOSPITAL   (Denmark)

Author keywords

Blood coagulation; Colorectal neoplasms; Fibrin and fibrinogen degradation products; Fibrinolysis; Thromboembolism

Indexed keywords

FIBRIN; FIBRINOGEN; FIBRINOGEN DEGRADATION PRODUCT;

ADULT; AGED; ARTICLE; CANCER GROWTH; CANCER LOCALIZATION; COLON ADENOCARCINOMA; COLON ADENOMA; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FIBRIN FORMATION; HUMAN; HUMAN CELL; HUMAN TISSUE; LIVER METASTASIS; MAJOR CLINICAL STUDY; MALE; PROTEIN BLOOD LEVEL; PROTEIN DETERMINATION;

EID: 0029738919     PISSN: 00123706     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02081408     Document Type: Article

References (22)

1. Zacharski LR, Wojtukiewicz MZ, Costantini V, Ornstein DL, Memoli VA. Pathway of coagulation/fibrinolysis activation in malignancy. Semin Thromb Hemost 1992;18:104-16.
2. Bergqvist D, Lindblad B. Thromboembolic problems in colorectal cancer surgery. Scand J Gastroentrol Suppl 1988;149:74-81.
3. Prandoni P, Lensing AW, Büller HR, et al. Deep vein thrombosis and the incidence of subsequent symptomatic cancer. N Engl J Med 1992;327:1128-33.
4. Costantini V, Zacharski LR. Fibrin and cancer. Thromb Haemost 1993;69:406-14.
5. Heimburger N, Pâques EP, Römich J. Coagulation and fibrinolysis in cancer. Behring Inst Mitt 1992;91:169-82.
6. Costantini V, Zacharski LR. The role of fibrin in tumor metastasis. Cancer Metastasis Rev 1992;11:283-90.
7. Kwaan HC. The plasminogen-plasmin system in malignancy. Cancer Metastasis Rev 1992;11:291-311.
8. de Bruin PA, Verspaget HW, Griffioen G, et al. Plasminogen activator activity and composition in human colorectal carcinomas. Fibrinolysis 1987;1:57-62.
9. Grøndahl-Hansen J, Ralfkiær E, Kirkeby LT, Kristensen P, Lund LR, Danø K. Localization of urokinase-type plasminogen activator in stromal cells in adenocarcinomas of the colon in humans. Am J Pathol 1991;138:111-7.
10. Dover R, Goeting NL, Taylor I, Roath OS, Francis JL. Factor X-activating activity in patients with colorectal carcinoma. Br J Surg 1987;74:1122-4.
11. Francis JL, El-Baruni OS, Taylor I. Factor X-activating activity in normal and malignant colorectal tissue. Thromb Res 1988;52:207-17.
12. Wojtukiewicz MZ, Zacharski LR, Memoli VA, et al. Indirect activation of blood coagulation in colon cancer. Thromb Haemost 1989;62:1062-6.
13. Szczepanski M, Bardadin K, Zawadzki J, Pypno W. Procoagulant activity of gastric, colorectal, and renal cancer is factor VII-dependent. J Cancer Res Clin Oncol 1988;114:519-22.
14. Parmar J, Taylor S, Roath S, Francis J. Procoagulant activity in whole blood from patients with breast and colorectal cancer. Blood Coagul Fibrinolysis 1990;1:127-32.
15. Abbasciano V, Levato F, Zavagli G. Specificity of fibrino-peptide A (FpA) as a marker for gastrointestinal cancers before and after surgery. Med Oncol Tumor Pharmacother 1987;4:75-9.
16. van Duijnhoven EM, Lustermans FA, van Wersch JW. Evaluation of the coagulation/fibrinolysis balance in patients with co-lorectal cancer. Haemostasis 1993;23:168-72.
17. McCulloch P, Nieuwenhuizen W, Douglas J, Lowe GD, George WD. Coagulation disturbances in cancer of the breast and colon measured with specific monoclonal antibody enzyme immunoassay for fibrin-fibrinogen degradation products. Haemostasis 1990;20:73-80.
18. Koopmann J, Haverkate F, Koppert O, Nieuwenhuizen W, Brommer EJ, Van Der Werf WG. New enzyme immunoassay of fibrin-fibrinogen degradation products in plasma using a monoclonal antibody. J Lab Clin Med 1987;109:75-84.
19. Edwards CM, Warrwen J, Armstrong L, Donnelly PK. D-dimer: a useful marker of disease stage in surgery for colorectal cancer. Br J Surg 1993;80:1404-5.
20. Kirchheimer JC, Huber K, Wagner O, Binder BR, Pattern of fibrinolytic parameters in patients with gastrointestinal carcinoma. Br J Haematol 1987;66:85-9.
21. de Jong E, Knot EA, Piket D, et al. Increased plasminogen activator inhibitor levels in malignancy. Thromb Haemost 1987;57:140-3.
22. Iversen LH, Thorlacius-Ussing O, Okholm M. Soluble fibrin in plasma before and after surgery for benign and malignant colorectal disease. Thromb Res 1995;79:471-81.